Long-Term Outcomes after Blinatumomab Treatment: Follow-up of a Phase 2 Study in Patients (Pts) with Minimal Residual Disease (MRD) Positive B-Cell Precursor Acute Lymphoblastic Leukemia (ALL)

Goekbuget, Nicola and Dombret, Herve and Bonifacio, Massimiliano and Reichle, Albrecht and Graux, Carlos and Faul, Christoph and Diedrich, Helmut and Topp, Max S. and Brueggemann, Monika and Horst, Heinz A. and Stieglmaier, Julia and Wessels, Hendrik and Haddad, Vincent and Zugmaier, Gerhard and Nagorsen, Dirk and Bargou, Ralf C. (2015) Long-Term Outcomes after Blinatumomab Treatment: Follow-up of a Phase 2 Study in Patients (Pts) with Minimal Residual Disease (MRD) Positive B-Cell Precursor Acute Lymphoblastic Leukemia (ALL). BLOOD, 126 (23): 680. ISSN 0006-4971, 1528-0020

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie)
Depositing User: Petra Gürster
Date Deposited: 26 Aug 2020 10:35
Last Modified: 26 Aug 2020 10:35
URI: https://pred.uni-regensburg.de/id/eprint/4304

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.